Table 1.
Control group (n = 8) | DPP4i group (n = 8) | p | |
---|---|---|---|
Fasting blood glucose, mg/dL | 452±75 | 366±84 | <0.05 |
HbA1c, % | 6.1±0.5 | 5.6±0.6 | <0.05 |
Fasting insulin, ng/mL | 0.16±0.04 | 0.17±0.05 | 0.67 |
AST, IU/L | 101±26 | 77±21 | <0.05 |
ALT, IU/L | 113±32 | 92±18 | <0.05 |
Total cholesterol, mg/dL | 158±18 | 144±20 | 0.34 |
Triglycerides, mg/dL | 425±124 | 310±101 | <0.05 |
Data are expressed as mean ± SD. Differences between the two groups were analyzed using the Wilcoxon rank-sum test.p values <0.05 were considered significant. DPP4i, dipeptidyl peptidase-4 inhibitor; HbA1c, hemoglobin A1c; AST, aspartate aminotransferase; ALT, alanine aminotransferase.